Dosing regimen to fingolimod FOR THE TREATMENT OF MULTIPLE SCLEROSIS
- 专利权人:
- NOVARTIS AG
- 发明人:
- SCHMOUDER, ROBERT,DUMORTIER, THOMAS,DAVID, OLIVIER,LOOBY, MICHAEL
- 申请号：
- DK09797234
- 公开号：
- DK2379067T3
- 申请日:
- 2009.12.21
- 申请国别(地区):
- DK
- 年份:
- 2015
- 代理人:
- 摘要：
- S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage.
- 来源网站：
- 中国工程科技知识中心
